Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY
Journal
Cancer science
Journal Volume
111
Journal Issue
12
Pages
4510-4525
Date Issued
2020
Author(s)
Nishio M.
Seto T.
Reck M.
Garon E.B.
Chiu C.-H.
Yoh K.
Imamura F.
Park K.
Visseren-Grul C.
Frimodt-Moller B.
Zimmermann A.
Homma G.
Enatsu S.
Nakagawa K.
RELAY Study Investigators
SDGs
Publisher
NLM (Medline)
Type
journal article
